Additionally, increased plasma levels of IL6, IL10, IL12, CCL2, CCL3, CXCL1, and VEGF and substantial central nervous system defects have been observed in patients with Farber disease [176,182]. Here, CCL2 is linked to Farber lipogranulomatosis.